This agrees with our observations of Annexin A2 suppression diminishing the migratory capacity of breast cancer cells (Figure 4C,D) and potentially correlating with loss of EMT marker, E-Cadherin, in specific cases (Figure 3A). This evidence concerns the gene CDH1 and breast cancer.